{
  "title": "Preimplantation genetic testing for aneuploidy versus no genetic testing in couples undergoing intracytoplasmic sperm injection for severe male infertility: multicentre, open label, randomised controlled trialTo test or not to test? A framework for counselling patients on preimplantation genetic testing for aneuploidy (PGT-A)Idiopathic recurrent miscarriage is caused mostly by aneuploid embryosLive birth with or without preimplantation genetic testing for aneuploidyMale infertilitySevere male factor in  fertilization: definition, prevalence, and treatment. An updateIntracytoplasmic sperm injection for\u00a0male infertility and consequences for\u00a0offspringInternational committee for monitoring assisted reproductive technologies world report: assisted reproductive technology 2008, 2009 and 2010Use of suboptimal sperm increases the risk of aneuploidy of the sex chromosomes in preimplantation blastocyst embryosFrequency, morbidity and equity - the case for increased research on male fertilityIntracytoplasmic sperm injection versus conventional in-vitro fertilisation for couples with infertility with non-severe male factor: a multicentre, open-label, randomised controlled trialPreimplantation genetic testing for aneuploidy in severe male factor infertilityComparison of preimplantation genetic testing for aneuploidy versus intracytoplasmic sperm injection in severe male infertilityWomen\u2019s preferences concerning IVF treatment: a discrete choice experiment with particular focus on embryo transfer policyPreimplantation genetic testing for aneuploidy in severe male factor infertility: protocol for a multicenter randomised controlled trialAntisperm Antibody Testing: A Comprehensive Review of Its Role in the Management of Immunological Male Infertility and Results of a Global Survey of Clinical PracticesBlastocyst culture and transfer: analysis of results and parameters affecting outcome in two in vitro fertilization programsFrozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trialThe use of copy number loads to designate mosaicism in blastocyst stage PGT-A cycles: fewer is betterDeveloping a core outcome set for future infertility research: an international consensus development studyMultiplicity Adjustment and Sample Size Calculation in Clinical Trials with Multiple Endpoints: An Industry Survey of Current Practices in JapanNeither relevant nor randomized: the use of \u201cper embryo transfer\u201d in the analysis of preimplantation genetic testing for aneuploidy trialsDiagnosis and treatment of infertility in men: AUA/ASRM guideline part IIThe diagnosis of male infertility: an analysis of the evidence to support the development of global WHO guidance-challenges and future research opportunitiesEffect of the male factor on the clinical outcome of intracytoplasmic sperm injection combined with preimplantation aneuploidy testing: observational longitudinal cohort study of 1,219 consecutive cyclesDo sperm factors influence embryonic aneuploidy? Long live the oocyteThe use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinionFrom oocytes to a live birth: Are we improving the biological efficiency?Noninvasive preimplantation genetic testing for aneuploidy in spent medium may be more reliable than trophectoderm biopsySteady morphokinetic progression is an independent predictor of live birth: a descriptive reference for euploid embryosImpact of trophectoderm biopsy for preimplantation genetic testing on obstetric and neonatal outcomes: a meta-analysisPreimplantation genetic testing and child health: a national register-based study",
  "pmcid": "12723751",
  "features": {
    "sample_size": {
      "present": true,
      "count": 4,
      "unique_matches": [
        "sample size",
        "n=450"
      ],
      "examples": [
        {
          "match": "sample size",
          "context": "ransfer. We determined that a sample size of 436 women (218 per group)"
        },
        {
          "match": "sample size",
          "context": "y protocol, and evaluated the sample size (n=450) for power because of"
        },
        {
          "match": "sample size",
          "context": "between the two outcomes, the sample size of 450 (225 per group) provid"
        }
      ]
    },
    "randomization": {
      "present": true,
      "count": 16,
      "unique_matches": [
        "randomisation",
        "randomise",
        "allocation"
      ],
      "examples": [
        {
          "match": "randomise",
          "context": "this multicentre, open label randomised controlled trial at four rep"
        },
        {
          "match": "randomise",
          "context": "the use of ICSI. Before this randomised controlled trial, nearly 300"
        },
        {
          "match": "randomisation",
          "context": "he first screening and before randomisation. After we obtained written in"
        }
      ]
    },
    "blinding": {
      "present": true,
      "count": 1,
      "unique_matches": [
        "masked"
      ],
      "examples": [
        {
          "match": "masked",
          "context": "sessing the outcomes were not masked to the group allocation. All"
        }
      ]
    },
    "allocation_concealment": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "interaction_subgroup": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "variable_definitions": {
      "present": true,
      "count": 1,
      "unique_matches": [
        "primary endpoint"
      ],
      "examples": [
        {
          "match": "primary endpoint",
          "context": "50) for power because of a co-primary endpoint design, using Hochberg\u2019s proc"
        }
      ]
    },
    "analysis_principles": {
      "present": true,
      "count": 3,
      "unique_matches": [
        "intention-to-treat"
      ],
      "examples": [
        {
          "match": "intention-to-treat",
          "context": "formed primary analyses on an intention-to-treat basis. Continuous variables a"
        },
        {
          "match": "intention-to-treat",
          "context": "embryo culture, and transfer (intention-to-treat analysis)  FOOTER: Data are n"
        },
        {
          "match": "intention-to-treat",
          "context": "etric and perinatal outcomes (intention-to-treat analysis)  FOOTER: Data are n"
        }
      ]
    },
    "itt_details": {
      "present": true,
      "count": 2,
      "unique_matches": [
        "intention-to-treat analysis"
      ],
      "examples": [
        {
          "match": "intention-to-treat analysis",
          "context": "embryo culture, and transfer (intention-to-treat analysis)  FOOTER: Data are number (%)"
        },
        {
          "match": "intention-to-treat analysis",
          "context": "etric and perinatal outcomes (intention-to-treat analysis)  FOOTER: Data are number (%)"
        }
      ]
    },
    "software": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "error_measures": {
      "present": true,
      "count": 10,
      "unique_matches": [
        "interquartile range",
        "standard deviation",
        "sd"
      ],
      "examples": [
        {
          "match": "standard deviation",
          "context": "es are reported as the means (standard deviation (SD)) or medians (interquarti"
        },
        {
          "match": "standard deviation",
          "context": "MII=metaphase II oocytes; SD=standard deviation; IQR=interquartile range. The"
        },
        {
          "match": "standard deviation",
          "context": "ic testing for aneuploidy; SD=standard deviation.22 women in the no PGT-A grou"
        }
      ]
    },
    "multiplicity_correction": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "normality_checks": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "p_values": {
      "present": true,
      "count": 4,
      "unique_matches": [
        "secondary outcome",
        "alpha"
      ],
      "examples": [
        {
          "match": "alpha",
          "context": "ed 80% power with a two sided alpha of 0.05 and an estimated drop"
        },
        {
          "match": "Secondary outcome",
          "context": "r of randomised participants. Secondary outcomes included biochemical pregnan"
        },
        {
          "match": "secondary outcome",
          "context": "yndrome.21 Definitions of the secondary outcomes are provided in the study pr"
        }
      ]
    },
    "confidence_intervals": {
      "present": true,
      "count": 4,
      "unique_matches": [
        "95% confidence",
        "95% ci",
        "confidence interval"
      ],
      "examples": [
        {
          "match": "95% CI",
          "context": "alysis, and hazard ratios and 95% CIs were calculated. We construc"
        },
        {
          "match": "confidence interval",
          "context": "nd odds ratios, both with 95% confidence intervals (CIs), using a binomial regr"
        },
        {
          "match": "confidence interval",
          "context": "testing for aneuploidies; CI=confidence interval; SD=standard deviation. The o"
        }
      ]
    },
    "comparative_stats": {
      "present": true,
      "count": 3,
      "unique_matches": [
        "\u03c72",
        "wilcoxon",
        "odds ratio"
      ],
      "examples": [
        {
          "match": "\u03c72",
          "context": "isons were analysed using the \u03c72 test. Primary outcomes were c"
        },
        {
          "match": "Wilcoxon",
          "context": "roups were analysed using the Wilcoxon rank sum test because of the"
        },
        {
          "match": "odds ratio",
          "context": "the absolute differences and odds ratios, both with 95% confidence in"
        }
      ]
    },
    "non_parametric": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "advanced_modeling": {
      "present": true,
      "count": 1,
      "unique_matches": [
        "linear mixed model"
      ],
      "examples": [
        {
          "match": "linear mixed model",
          "context": "ession model. The generalised linear mixed model was applied for the central e"
        }
      ]
    },
    "assumption_checks": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "survival_analysis": {
      "present": true,
      "count": 2,
      "unique_matches": [
        "kaplan-meier",
        "hazard ratio"
      ],
      "examples": [
        {
          "match": "Kaplan-Meier",
          "context": "re calculated. We constructed Kaplan-Meier curves compared them using th"
        },
        {
          "match": "hazard ratio",
          "context": "ortional hazard analysis, and hazard ratios and 95% CIs were calculated."
        }
      ]
    },
    "regression_and_models": {
      "present": true,
      "count": 1,
      "unique_matches": [
        "cox proportional"
      ],
      "examples": [
        {
          "match": "Cox proportional",
          "context": "live birth was assessed using Cox proportional hazard analysis, and hazard r"
        }
      ]
    },
    "reporting_guidelines": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "data_types": {
      "present": true,
      "count": 3,
      "unique_matches": [
        "frequencies",
        "categorical",
        "continuous"
      ],
      "examples": [
        {
          "match": "categorical",
          "context": "e variables. We have reported categorical variables as frequencies and"
        },
        {
          "match": "Continuous",
          "context": "an intention-to-treat basis. Continuous variables are reported as the"
        },
        {
          "match": "frequencies",
          "context": "rted categorical variables as frequencies and percentages and between-g"
        }
      ]
    },
    "dependency": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "clustering": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "missing_data": {
      "present": true,
      "count": 4,
      "unique_matches": [
        "missing data",
        "dropout",
        "imputation"
      ],
      "examples": [
        {
          "match": "missing data",
          "context": "tation analyses were used for missing data. We also conducted a per prot"
        },
        {
          "match": "dropout",
          "context": "el of 0.05, with an estimated dropout rate of 20%. We ultimately re"
        },
        {
          "match": "dropout",
          "context": "lpha of 0.05 and an estimated dropout rate of 20%. We performed pri"
        }
      ]
    },
    "effect_size": {
      "present": true,
      "count": 2,
      "unique_matches": [
        "hazard ratio",
        "odds ratio"
      ],
      "examples": [
        {
          "match": "odds ratio",
          "context": "the absolute differences and odds ratios, both with 95% confidence in"
        },
        {
          "match": "hazard ratio",
          "context": "ortional hazard analysis, and hazard ratios and 95% CIs were calculated."
        }
      ]
    },
    "post_hoc": {
      "present": true,
      "count": 1,
      "unique_matches": [
        "post hoc"
      ],
      "examples": [
        {
          "match": "post hoc",
          "context": "ndary outcomes, and performed post hoc analysis for primary outcomes"
        }
      ]
    },
    "baseline_reporting": {
      "present": true,
      "count": 1,
      "unique_matches": [
        "baseline characteristic"
      ],
      "examples": [
        {
          "match": "Baseline characteristic",
          "context": "public involvement. CAPTION: Baseline characteristics of all randomised participan"
        }
      ]
    },
    "advanced_modeling_extra": {
      "present": true,
      "count": 1,
      "unique_matches": [
        "excluded"
      ],
      "examples": [
        {
          "match": "excluded",
          "context": "cated to the PGT-A group were excluded because they required only in"
        }
      ]
    },
    "systematic_review_metrics": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "diagnostic_metrics": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "model_details": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "domain_indicators": {
      "present": true,
      "count": 1,
      "unique_matches": [
        "in vitro"
      ],
      "examples": [
        {
          "match": "in vitro",
          "context": "m PGT-A. The annual number of in vitro fertilisation cycles in the f"
        }
      ]
    }
  },
  "feedback": {
    "overall_score": 4.0,
    "rigor_rating": "Low",
    "critical_gaps": [
      {
        "message": "P-values reported without effect sizes (e.g. Odds Ratio).",
        "evidence": "...ed 80% power with a two sided alpha of 0.05 and an estimated drop..."
      },
      {
        "message": "Includes exploratory/post hoc analyses without clear multiplicity correction.",
        "evidence": "...ndary outcomes, and performed post hoc analysis for primary outcomes..."
      },
      {
        "message": "Categorical data mentioned, but no appropriate categorical tests found.",
        "evidence": "...e variables. We have reported categorical variables as frequencies and..."
      },
      {
        "message": "Survival analysis used without verifying proportional hazards assumption.",
        "evidence": "...re calculated. We constructed Kaplan-Meier curves compared them using th..."
      }
    ],
    "strengths": [
      {
        "message": "Analysis context identifies basic science or bioinformatics (Softened clinical trial requirements).",
        "evidence": "Detected term: 'in vitro'"
      },
      {
        "message": "Addressed missing data using imputation methods.",
        "evidence": "...tation analyses were used for missing data. We also conducted a per prot..."
      },
      {
        "message": "Exclusion criteria explicitly defined (transparency).",
        "evidence": "...cated to the PGT-A group were excluded because they required only in..."
      }
    ],
    "actionable_recommendations": [
      {
        "item": "Deductive Rigor",
        "issue": "Post hoc findings are hypothesis-generating.",
        "recommendation": "Distinguish between pre-specified endpoints and exploratory analyses.",
        "source_text": "Found term 'post hoc' without rigorous correction."
      }
    ],
    "deterministic_audit": true
  }
}